These results indicate a previously unrecognized feedback loop consisting of OTUD6B, pVHL, and HIF‐1α, and provide insights into the targeted hypoxic microenvironment for HCC therapy. The gene discussed is OTUD6B; the disease is hepatocellular carcinoma.